Martin Heather 4

What Happened Martin Heather, Chief Marketing Officer and Chief of Staff at Anterix (ATEX), received equity awards on May 20, 2026: 3,694 restricted stock units (RSUs) and 17,453 derivative/option-style shares were granted at a reported acquisition price of $0. The filing reports these as awards/grants (code A) rather than purchases or sales, so there was no cash exchanged and no immediate change in market exposure from a sale or buy.

Key Details

• Transaction date: May 20, 2026; Filing date: May 22, 2026 (filed within the standard two-business-day window).
• Reported price: $0.00 for both grants (typical for compensation awards).
• Grant amounts: 3,694 RSUs (footnote F1) and 17,453 option-style/derivative awards (footnote F2).
• Shares owned after transaction: Not specified in the provided excerpt.
• Vesting/terms (from filing footnotes):
  • F1 (RSUs): Vest over three years — 1/3 vests on May 20, 2027, then 1/12 vests quarterly on Aug 10, Nov 10, Feb 10 and May 20 through May 20, 2029.
  • F2 (option-style awards): Same three-year vesting schedule — 1/3 on May 20, 2027, then 1/12 quarterly on the same schedule through May 20, 2029.
• No indication these awards were exercised or sold; they are grants/longer-term compensation.

Context These grants are typical equity compensation for executives and are not the same as an open-market purchase (which some investors view as a bullish signal) or a sale (which can be liquidity-taking). The derivative award will only convert to exercisable shares as it vests per the schedule above; until then it represents future potential ownership contingent on continued service and vesting conditions.